A new study has found that a common type of cancer treatment, called immune checkpoint inhibitors (ICIs), may not be very effective for patients who...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut...

New research findings were reported today from the ENZA-p study (ANZUP 1901), led by the Australian and New Zealand Urogenital and Prostate Cancer...

Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically...

Red light therapy is increasingly viewed as a promising treatment for wrinkles, acne, psoriasis, scars and sun-damaged skin, and as a supportive...

A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI), UK, has found that high-precision radiation therapy is...

A new experimental vaccine could provide fresh hope for women diagnosed with triple-negative breast cancer, a particularly aggressive and...

A decade-long follow-up from the ShortHER randomised clinical trial suggests that tumour-infiltrating lymphocytes (TILs) could play a pivotal role in...

In a randomised clinical trial, researchers from Huntsman Cancer Institute at the University of Utah, USA, (the U) have found that short-course,...

An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune...